Alvocade®

Bortezomib

Feel it in your bones

Product Information

  • Proprietary Name: Alvocade®
  • Generic Name: Bortezomib
  • Dosage Form: Vial
  • Strengths: 2.5 mg, 3.5 mg
  • Indications: Multiple Myeloma, Mantle Cell Lymphoma
Download Leaflet

Oncology

Alvocade®

Bortezomib is indicated for the treatment of multiple myeloma, and mantle cell lymphoma.

© NanoAlvand. All rights reserved. Powered by ِDGN.